Advanced imaging techniques for better breast cancer diagnosis and treatment
Next generation deep tissue quantitative optical imaging
This study is working on a new way to take pictures of breast tissue using special light techniques to help doctors better tell the difference between cancer and healthy tissue, which could lead to more personalized treatment plans for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Notre Dame NIH-funded |
| Lab location | 1 site (Notre Dame, United States) |
| Project ID | NIH-10770422 on NIH RePORTER |
What this research studies
This research focuses on developing a new imaging platform that uses advanced near-infrared optical imaging techniques to improve the diagnosis and treatment of breast cancer. By utilizing frequency domain diffuse optical spectroscopy (FD-DOS), the project aims to achieve deeper imaging capabilities that can better differentiate between cancerous and non-cancerous tissues. The approach seeks to enhance the accuracy of predicting individual responses to chemotherapy and other treatments, ultimately leading to more personalized care for patients. The research also addresses current limitations in imaging resolution and usability to facilitate clinical adoption.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with breast cancer who are undergoing treatment.
Not a fit: Patients with non-breast cancer-related conditions or those who are not undergoing treatment for breast cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate and personalized treatment options for breast cancer patients.
How similar studies have performed: Previous research has shown promising results using similar imaging techniques, but this specific approach aims to overcome existing barriers and enhance clinical application.
Where this research is happening
Notre Dame, United States
- University of Notre Dame — Notre Dame, United States (Active)
Researchers
- Principal investigator: Osullivan, Thomas D — University of Notre Dame
- Study coordinator: Osullivan, Thomas D
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.